Brainomix in collaboration with UK Government-funded NCIMI
Partnership will evaluate AI-powered technology in lung cancer care
Read MorePartnership will evaluate AI-powered technology in lung cancer care
Read MoreMedicines repurposing offers new avenues for treating a range of common and rare diseases
Read MoreFirst EU public-private collaboration for production of saRNA-based vaccines
Read MoreThe companies will aim to improve treatment for patients with prostate, breast and lung cancer
Read MoreThe Airport Region in Central Germany’ presents itself as an attractive location for the international pharmaceutical industry
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
